Your browser doesn't support javascript.
loading
Pyoderma gangrenosum after mRNA-based SARS-CoV-2 vaccine.
Franceschi, J; Darrigade, A S; Sanchez-Pena, P; Legrain-Lifermann, V; Milpied, B.
Afiliação
  • Franceschi J; Department of Dermatology, Bordeaux University Hospital, Bordeaux cedex, France.
  • Darrigade AS; Department of Dermatology, Bordeaux University Hospital, Bordeaux cedex, France.
  • Sanchez-Pena P; Regional Center of Pharmacovigilance, Pharmacology Department, Bordeaux University Hospital, Bordeaux cedex, France.
  • Legrain-Lifermann V; Department of Dermatology, Dax Hospital, Dax, France.
  • Milpied B; Department of Dermatology, Bordeaux University Hospital, Bordeaux cedex, France.
J Eur Acad Dermatol Venereol ; 36(12): e969-e970, 2022 12.
Article em En | MEDLINE | ID: mdl-35771124
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pioderma Gangrenoso / COVID-19 Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pioderma Gangrenoso / COVID-19 Idioma: En Ano de publicação: 2022 Tipo de documento: Article